Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously reported that
acetylcholinesterase
plays a critical role in apoptosis and its expression is regulated by Ca(2+) mobilization. In the present study, we show that activated calpain, a cytosolic calcium-activated cysteine protease, and calcineurin, a calcium-dependent protein phosphatase, regulate
acetylcholinesterase
expression during A23187-induced apoptosis. The calpain inhibitor, calpeptin, and the calcineurin inhibitors, FK506 and cyclosporine A, inhibited
acetylcholinesterase
expression at both mRNA and protein levels and suppressed the activity of the human
acetylcholinesterase
promoter. In contrast, overexpression of constitutively active calcineurin significantly activated the
acetylcholinesterase
promoter. Furthermore, we identify a role for the transcription factor NFAT (nuclear factor of activated T cells), a calcineurin target, in regulating the
acetylcholinesterase
promoter during ionophore-induced apoptosis. Overexpression of human NFATc3 and
NFATc4
greatly increased the
acetylcholinesterase
promoter activity in HeLa cells treated with A23187. Overexpression of constitutive nuclear
NFATc4
activated the
acetylcholinesterase
promoter independent of A23187, whereas overexpression of dominant-negative NFAT blocked A23187-induced
acetylcholinesterase
promoter activation. These results indicate that calcineurin mediates
acetylcholinesterase
expression during apoptosis.
...
PMID:Calcineurin mediates acetylcholinesterase expression during calcium ionophore A23187-induced HeLa cell apoptosis. 1732 Feb 3